Search Within

Hematologic Malignancies Service

Formats
  1. Journal Article (350)
  2. Meeting Abstract (237)
  3. Review (11)
  4. Research Letter (5)
  5. Editorial (4)
  6. Book Section (2)
  7. Conference Paper (2)
  8. Guidelines (2)
  9. Correspondence (1)
Groups
  1. Pediatrics, Department of (614)
  2. Center for Hematologic Malignancies (557)
  3. Pediatric Leukemia (457)
  4. GSK Faculty (222)
  5. Tow Center for Developmental Oncology (TCDO) (208)
  6. Department of Medicine (150)

More Groups

People
  1. Peter Steinherz (221)
  2. Neerav Shukla (161)
  3. Tanya Trippett (126)
  4. Alex Kentsis (104)
  5. Christopher Forlenza (51)
  6. Marc Ladanyi (45)

More People

Years
  1. 2025 (13)
  2. 2024 (32)
  3. 2023 (37)
  4. 2022 (34)
  5. 2021 (29)
  6. 2020 (29)

More Years

Publications
  1. Blood (130)
  2. Journal of Clinical Oncology (61)
  3. Pediatric Blood and Cancer (57)
  4. Cancer Research (22)
  5. Cancer (18)
  6. Clinical Cancer Research (16)

More Publications

Publishers
  1. American Society of Hematology (139)
  2. American Society of Clinical Oncology (69)
  3. American Association for Cancer Research (57)
  4. Wiley Periodicals, Inc (57)
  5. Nature Publishing Group (39)
  6. Elsevier Inc. (31)

More Publishers

Results (614)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Initial results from a phase 2 study of blinatumomab in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
    Meeting Abstract

    Gore, L.; Locatelli, F.; Zugmaier, G.; Zwaan, C. M.; Bhojwani, D.; Handgretinger, R.; Bader, P.; O'Brien, M. M.; Trippett, T. M.; Brethon, B.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Greater total dose and duration of treatment with bortezomib are associated with higher incidence of chalazion and other ocular side effects
    Meeting Abstract

    Ganesh, K.; Batlevi, C.; Zhang, Z. G.; Hassoun, H.; Lendvai, N.; Landau, H.; Moskowitz, C. H.; Caron, P.; Motzer, R.; Giralt, S. A.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Interim analysis of a phase 1 study of the antibody-drug conjugate SGN-CD19A in relapsed or refractory B-lineage acute leukemia and highly aggressive lymphoma
    Meeting Abstract

    Fathi, A. T.; Chen, R.; Trippett, T. M.; O'Brien, M. M.; DeAngelo, D. J.; Shah, B. D.; Cooper, T. M.; Foran, J. M.; Hale, G. A.; Pressey, J.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Selective inhibitor of nuclear export (SINE), selinexor (KPT-330), shows remarkable activity against AML leukemia-initiating cells
    Meeting Abstract

    Etchin, J.; Le, B. T.; Kentsis, A.; Mansour, M. R.; Berezovskaya, A.; Stone, R. M.; Galinsky, I.; DeAngelo, D. J.; McCauley, D.; Kauffman, M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Chimeric antigen receptor (CAR) T cells targeting the CD19 antigen for the treatment of pediatric relapsed B cell ALL
    Meeting Abstract

    Curran, K. J.; Riviere, I.; Kobos, R.; Kernan, N. A.; Boulad, F.; Prockop, S. E.; Scaradavou, A.; Renaud, T. M.; Shukla, N.; Steinherz, P. G.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Utility of combined DNA and RNA next generation sequencing in leukemias for identification of prognostic and therapeutically relevant genomic alterations in clinical practice
    Meeting Abstract

    Coombs, C. C.; Viny, A. D.; He, J.; Kobos, R.; Lipson, D.; Shukla, N.; Knapp, K. M.; Otto, G.; Abdel-Wahab, O.; Stein, E. M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Druggability of p16 deleted pediatric leukemia: The novel cell line POETIC3 identifies potential agents and drug combinations for mechanism based targeted therapeutics
    Meeting Abstract

    Reimer, J.; Kovulchuk, A.; Ruan, Y.; Shah, R.; Jayanthan, A.; Perinpanayagam, M.; Truong, T.; Auer-Grzesiak, I.; Luider, J.; Kovulchuk, O.; more...
    European Journal of Cancer (2014)

    Fulltext@MSK | Save
  • Blinatumomab in pediatric patients with relapsed/refractory (R/R) B-cell precursor acute lymphoblastic leukemia (Bcp-All): A phase 1/2 study
    Meeting Abstract

    Whitlock, J.; Von Stackelberg, A.; Handgretinger, R.; Locatelli, F.; Rizzari, C.; Trippett, T.; Borkhardt, A.; O'brien, M.; Rheingold, S.; Gore, L.
    Pediatric Blood and Cancer (2014)

    Fulltext@MSK | Save
  • High-dose cyclophosphamide for the treatment of refractory T-cell acute lymphoblastic leukemia in children
    Journal Article

    Kobos, R.; Shukla, N.; Renaud, T.; Prockop, S. E.; Boulad, F.; Steinherz, P. G.
    Journal of Pediatric Hematology/Oncology (2014)

    Fulltext@MSK | Save
  • Prolonged hypogammaglobulinemia in pediatric lymphoma patients after rituximab therapy
    Meeting Abstract

    Terry, W.; Shukla, N.; Renaud, T.; Kernan, N.; Chaudhuri, J.; Steinherz, P.; Kobos, R.
    Pediatric Blood and Cancer (2014)

    Fulltext@MSK | Save